Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Hematology
•
Rheumatoid Arthritis
How would you manage a patient with RA with newly diagnosed T-LGLL who was previously treated with Enbrel and is now flaring off Enbrel while on low dose methotrexate?
Related Questions
How do you help patients understand the difference between prolonged morning stiffness and pain?
What biologics would you use in a patient with rheumatoid arthritis who developed multiple basal cell carcinomas requiring Mohs surgery while on a TNF-inhibitor and did not respond to rituximab?
How do you approach treatment selection in patients with rheumatoid arthritis and severe COPD?
Do you have any experience with compounded iguratimod either as adjunctive therapy or monotherapy for rheumatoid arthritis, Sjogrens, or axial spondyloarthropathy?
How do you manage oral ulcers as a side effect from leflunomide?
Excluding CLL, in which patients would you screen for hypogammaglobulinemia?
Would you consider using a JAK inhibitor for a patient with RA associated scleritis?
How would you treat suspected secondary HLH in patients whom etoposide is contraindicated?
How would you approach a patient with seronegative RA and ILD?
What is your approach to choosing a particular advanced therapy based on patient or disease factors when initiating treatment for moderate-severe IBD?